143 related articles for article (PubMed ID: 24093105)
21. The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model.
San Román B; De Andrés X; Muñoz PM; Obregón P; Asensio AC; Garrido V; Mansilla C; Arribillaga L; Lasarte JJ; De Andrés D; Amorena B; Grilló MJ
Vaccine; 2012 Mar; 30(15):2564-9. PubMed ID: 22326778
[TBL] [Abstract][Full Text] [Related]
22. The extra domain A of fibronectin activates Toll-like receptor 4.
Okamura Y; Watari M; Jerud ES; Young DW; Ishizaka ST; Rose J; Chow JC; Strauss JF
J Biol Chem; 2001 Mar; 276(13):10229-33. PubMed ID: 11150311
[TBL] [Abstract][Full Text] [Related]
23. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.
Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J
Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764
[TBL] [Abstract][Full Text] [Related]
24. The vaccine adjuvant extra domain A from fibronectin retains its proinflammatory properties when expressed in tobacco chloroplasts.
Farran I; McCarthy-Suárez I; Río-Manterola F; Mansilla C; Lasarte JJ; Mingo-Castel AM
Planta; 2010 Mar; 231(4):977-90. PubMed ID: 20108000
[TBL] [Abstract][Full Text] [Related]
25. The extradomain a of fibronectin enhances the efficacy of lipopolysaccharide defective Salmonella bacterins as vaccines in mice.
Román BS; Garrido V; Muñoz PM; Arribillaga L; García B; De Andrés X; Zabaleta V; Mansilla C; Farrán I; Lasa I; De Andrés D; Amorena B; Lasarte JJ; Grilló MJ
Vet Res; 2012 Apr; 43(1):31. PubMed ID: 22515195
[TBL] [Abstract][Full Text] [Related]
26. MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses.
Boks MA; Ambrosini M; Bruijns SC; Kalay H; van Bloois L; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Oct; 216():37-46. PubMed ID: 26151293
[TBL] [Abstract][Full Text] [Related]
27. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
[TBL] [Abstract][Full Text] [Related]
28. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
29. Antibody-mimetic ligand selected by mRNA display targets DC-SIGN for dendritic cell-directed antigen delivery.
Xiao L; Hung KC; Takahashi TT; Joo KI; Lim M; Roberts RW; Wang P
ACS Chem Biol; 2013 May; 8(5):967-77. PubMed ID: 23427768
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C lipo-Viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell.
Agaugué S; Perrin-Cocon L; André P; Lotteau V
PLoS One; 2007 Mar; 2(3):e330. PubMed ID: 17389921
[TBL] [Abstract][Full Text] [Related]
31. Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses.
Dadaglio G; Fayolle C; Zhang X; Ryffel B; Oberkampf M; Felix T; Hervas-Stubbs S; Osicka R; Sebo P; Ladant D; Leclerc C
J Immunol; 2014 Aug; 193(4):1787-98. PubMed ID: 25024388
[TBL] [Abstract][Full Text] [Related]
32. Psoriasis and extra domain A fibronectin loops.
McFadden JP; Baker BS; Powles AV; Fry L
Br J Dermatol; 2010 Jul; 163(1):5-11. PubMed ID: 20192957
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
[TBL] [Abstract][Full Text] [Related]
34. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor.
Wang QC; Feng ZH; Zhou YX; Nie QH
World J Gastroenterol; 2005 Jan; 11(4):557-60. PubMed ID: 15641145
[TBL] [Abstract][Full Text] [Related]
35. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
36. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
[TBL] [Abstract][Full Text] [Related]
37. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
Tsuji T; Matsuzaki J; Kelly MP; Ramakrishna V; Vitale L; He LZ; Keler T; Odunsi K; Old LJ; Ritter G; Gnjatic S
J Immunol; 2011 Jan; 186(2):1218-27. PubMed ID: 21149605
[TBL] [Abstract][Full Text] [Related]
38. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
39. Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
Lei Y; Shao J; Ma F; Lei C; Chang H; Zhang Y
Mol Immunol; 2020 May; 121():118-126. PubMed ID: 32199211
[TBL] [Abstract][Full Text] [Related]
40. Deletion of the mucin-like molecule muc1 enhances dendritic cell activation in response to toll-like receptor ligands.
Williams MA; Bauer S; Lu W; Guo J; Walter S; Bushnell TP; Lillehoj EP; Georas SN
J Innate Immun; 2010; 2(2):123-43. PubMed ID: 20375631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
